ACO

ACO Reporting Information


ACO Name and Location

  • Westchester Medical Group, P.C. (d/b/a WESTMED Medical Group)
    Administrative Office: 2700 Westchester Avenue, Purchase, NY 10577, 914-682-0700.

ACO Primary Contact

 

Mary Ellen Feller, ACO Project Manager
aco@westmedgroup.com
914-831-6852

Organizational Information:

  • ACO participants:
    WESTMED Medical Group, a multispecialty group practice is the sole participant in the ACO and all WESTMED physicians are part of the ACO.
  • ACO participants in joint ventures between ACO professional and hospitals:
    No participants are involved in a joint venture between ACO professionals and hospitals
  • ACO governing body:
    1. Michael Suzman, MD, Chairman/Voting Member, ACO Participant, Westchester Medical Group, P.C.
    2. Michael Cushner, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    3. Jenifer Johnson, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    4. Jonathan Finegold, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    5. Cordelia Schwarz, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    6. Randy Stein, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    7. Ronald Dennett, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    8. Monica Rieckhoff, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
    9. Joshua Waldman, MD, Voting Member, ACO Participant, Westchester Medical Group, P.C.
     
  • ACO Advisory Committee:
    1. Mr. Andrew Benerofe, Medicare Beneficiary Representative
    2. Mr. Arthur Doran, Jr. , Medicare Beneficiary Representative
    3. Mr. Paul Hicks, Medicare Beneficiary Representative
    4. Mr. Irwin Zamore, Medicare Beneficiary Representative
    5. Dr. Arthur Forni, ACO Provider, Westchester Medical Group, P.C.
    6. Dr. Jenifer Johnson, ACO Governing Body member (see above)
    7. Dr. Randy Stein, ACO Governing Body member (see above)
    8. Dr. Steven Meixler, Medical Director, ACO Participant, Westchester Medical Group, P.C.
     
  • Key ACO clinical and administrative leadership:
    1. Steven Meixler, MD (ACO Executive)
    2. Steven Meixler, MD (Medical Director)
    3. Toni Mileo Drohan, Esq. (Compliance Officer)
    4. Steven Meixler, Medical Director (Quality Assurance/Improvement Officer)
     
  • Associated committees and committee leadership:
    1. ACO Advisory Committee: Steven Meixler, MD and Arthur Forni, MD (Co-Chairs)
    2. ACO Steering Committee: Steven Meixler, MD and Arthur Forni, MD (Co-Chairs)
     
  • Types of ACO participants or combination of participants that formed the ACO:
    1. ACO professionals in a group practice arrangement
     

Shared Savings and Losses:

Amount of Shared Savings/Losses

  • Agreement period beginning 2012, Performance Year 1: $0.
  • Agreement period beginning 2012, Performance Year 2014: $3,266,226.
  • Agreement period beginning 2012, Performance Year 2015: $0.

Shared Savings Distribution

Agreement period beginning 2012, Performance Year 1
  • Proportion invested in infrastructure: 0%.
  • Proportion invested in redesigned care processes/resources: 0%.
  • Proportion of distribution to ACO participants: 0%.
Agreement period beginning 2012, Performance Year 2014
  • Proportion invested in infrastructure: 40%.
  • Proportion invested in redesigned care processes/resources: 0%.
  • Proportion of distribution to ACO participants: 60%.
Agreement period beginning 2012, Performance Year 2015
  • Proportion invested in infrastructure: 0%.
  • Proportion invested in redesigned care processes/resources: 0%.
  • Proportion of distribution to ACO participants: 0%.

Payment Rule Waivers

  • No, our ACO does not utilize the SNF 3-Day Rule Waiver.

Quality Performance Results

 

2015 Quality Performance Results Table

Measure number
Measure Name
2015 reporting period
ACO Mean performance rate
  performance rate (SSP-ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 84.86 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 94.93 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 93.49 91.94
ACO-4 CAHPS: Access to Specialists 87.66 83.61
ACO-5 CAHPS: Health Promotion and Education 60.37 59.06
ACO-6 CAHPS: Shared Decision Making 70.77 75.17
ACO-7 CAHPS: Health Status/Functional Status 75.34 72.30
ACO-34 CAHPS: Stewardship of Patient Resources* 17.28 26.87
ACO-8 Risk Standardized, All Condition Readmission 13.95 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission 16.33 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 49.43 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with HeartFailure* 59.32 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 49.76 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.03 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: HeartFailure (AHRQ Prevention Quality Indicator (PQI) #8) 0.81 1.04
ACO-11 Percent of Primary Care Physicians who SuccessfullyMeet Meaningful Use Requirements 88.61% 80.14%
ACO-39 Documentation of Current Medications in the Medical Record* 54.32% 84.07%
ACO-13 Falls: Screening for Future Fall Risk 66.72% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization 73.16% 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 84.83% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI)Screening and Follow-up 77.81% 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use:Screening and Cessation Intervention 99.18% 90.16%
ACO-18 Preventive Care and Screening: Screening for ClinicalDepression and Follow-up Plan 62.97% 45.25%
ACO-19 Colorectal Cancer Screening 80.65% 60.06%
ACO-20 Breast Cancer Screening 82.06% 65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 87.74% 70.04%
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 9.98% 20.38%
ACO-41 Diabetes: Eye Exam* 81.22% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure 76.77% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or AnotherAntithrombotic 80.93% 83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 91.43% 87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular SystolicDysfunction (LVEF<40%) 92.31% 77.73%
CAHPS =Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular
systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A


2012-2014 Quality Performance Results Table

Measure number
Performance measure
2012 reporting period 2013 reporting period 2014 reporting period
     
ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for All ACOs
ACO-1 Getting Timely Care, Appointments, and Information 84.55% 81.69% 83.05% 81.48% 81.87% 80.13%
ACO-2 How Well Your Doctors Communicate 94.29% 92.84% 93.62% 92.96% 92.34% 92.39%
ACO-3 Patients’ Rating of Doctor 92.80% 91.86% 92.93% 92.06% 92.77% 91.58%
ACO-4 Access to Specialists 87.48% 85.11% 86.64% 85.12% 85.23% 83.97%
ACO-5 Health Promotion and Education 61.09% 56.61% 58.06% 58.38% 56.66% 58.29%
ACO-6 Shared Decision Making 74.98% 73.99% 72.27% 74.53% 75.44% 74.60%
ACO-7 Health Status/Functional Status 69.94% 70.35% 72.81% 71.12% 73.44% 71.10%
ACO-8 Risk Standardized, All Condition Readmissions 16.16% 15.42% 14.40% 14.90% 14.75% 15.15%
ACO-9 ASC Admissions: COPD or Asthma in Older Adults 1.15% 1.13% 1.28% 1.17% 0.74% 1.08%
ACO-10 ASC Admission: Heart Failure 1.04% 1.09% 1.18% 1.20% 0.73% 1.19%
ACO-11 Percent of PCPs who Qualified for EHR Incentive Payment 80.00% 59.87% 63.89% 66.21% 88.89% 76.71%
ACO-12 Medication Reconciliation 92.70% 72.37% 97.86% 73.56% 95.74% 82.61%
ACO-13 Falls: Screening for Fall Risk 38.55% 28.27% 41.11% 39.57% 50.57% 45.60%
ACO-14 Influenza Immunization 54.49% 50.58% 61.69% 56.93% 70.85% 57.51%
ACO-15 Pneumococcal Vaccination 61.90% 48.62% 75.86% 54.76% 79.77% 55.03%
ACO-16 Adult Weight Screening and Follow-up 56.46% 53.91% 79.90% 61.61% 80.10% 66.75%
ACO-17 Tobacco Use Assessment and Cessation Intervention 95.07% 80.12% 98.05% 84.01% 99.18% 86.79%
ACO-18 Depression Screening 46.68% 22.48% 39.85% 31.19% 48.13% 39.27%
ACO-19 Colorectal Cancer Screening 76.80% 50.21% 77.29% 59.30% 78.33% 56.14%
ACO-20 Mammography Screening 67.05% 62.23% 74.84% 62.05% 81.76% 61.41%
ACO-21 Proportion of Adults who had blood pressure screened in past 2 years 0.49% 71.56% 32.06% 74.25% 34.08% 60.24%
ACO-22 Hemoglobin A1c Control (HbA1c) (< 8 percent) 75.94% N/A 83.75% N/A 82.20% N/A
ACO-23 Low Density Lipoprotein (LDL) (< 100 mg/dL) 72.53% N/A 73.31% N/A N/A N/A
ACO-24 Blood Pressure (BP) < 140/90 73.89% N/A 75.24% N/A 78.70% N/A
ACO-25 Tobacco Non-Use 91.47% N/A 92.65% N/A 93.68% N/A
ACO-26 Aspirin Use 90.53% N/A 89.02% N/A 89.33% N/A
ACO-27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 12.97% 25.94% 7.35% 22.11% 9.82% 20.35%
ACO-28 Percent of beneficiaries with hypertension whose BP < 140/90 63.73% 63.22% 68.38% 67.79% 75.22% 68.02%
ACO-29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl 72.15% 52.02% 71.49% 55.44% N/A N/A
ACO-30 Percent of beneficiaries who use Aspirin or other antithrombotic 80.26% 72.60% 78.61% 76.35% 81.90% 80.79%
ACO-31 Beta-Blocker Therapy for LVSD 90.00% 79.60% 95.24% 79.82% 86.84% 82.71%
ACO-32 Drug Therapy for Lowering LDL-Cholesterol 83.05% N/A 81.20% N/A N/A N/A
ACO-33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or (LVSD) 81.88% N/A 76.56% N/A 85.58% N/A 

 

 

Note: ASC = ambulatory sensitive conditions, COPD=chronic obstructive pulmonary disease, EHR=electronic health record, IVD=ischemic vascular disease, LVSD=left ventricular systolic  

dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.